In the pharmaceutical industry, regulatory affairs in drug development and quality assurance (QA) are both essential for ensuring compliance and product quality, but their roles are different. Regulatory Affairs focuses on regulatory requirements, submissions, approvals, and communication with health authorities. The role of regulatory affairs in drug development is to guide a medicine through the regulatory pathway from development to market approval. Quality Assurance (QA) focuses on maintaining quality systems, GMP compliance, SOPs, audits, and controlled processes to ensure consistent product quality. In simple terms, regulatory affairs drug development focuses on regulatory compliance and approval, while QA focuses on quality and process compliance. Both are important for successful regulatory affairs and drug development. Conclusion Regulatory Affairs and QA have different responsibilities but work together to support safe, compliant, and high-quality medicines. Molkem supports the pharmaceutical industry with expertise that contributes to effective regulatory and quality practices.